| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.1 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.1 |